Inhaled corticosteroids for bronchopulmonary dysplasia: A meta-analysis

Pediatrics

Volumn 138, Issue 6, 2016, Pages

  Shinwell, Eric S ^a   Portnov, Igor ^a   Meerpohl, Joerg J ^b   Karen, Tanja ^c   Bassler, Dirk ^c  

^a BAR ILAN UNIVERSITY   (Israel)

^b PARIS DESCARTES UNIVERSITY   (France)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; DEXAMETHASONE; FLUNISOLIDE; FLUTICASONE; PLACEBO;

ARTICLE; ARTIFICIAL VENTILATION; BRAIN HEMORRHAGE; CHEMOPROPHYLAXIS; CORTICOSTEROID THERAPY; DIGESTIVE SYSTEM PERFORATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; LEUKOMALACIA; LUNG DYSPLASIA; META ANALYSIS; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OXYGEN THERAPY; PERIVENTRICULAR LEUKOMALACIA; PREMATURITY; PRIORITY JOURNAL; QUALITY CONTROL; RANDOM EFFECTS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; STATISTICAL MODEL; SYSTEMIC THERAPY; TIME SERIES ANALYSIS; TREATMENT DURATION; TREND STUDY; BRONCHOPULMONARY DYSPLASIA; FEMALE; GESTATIONAL AGE; INHALATIONAL DRUG ADMINISTRATION; MALE; NEWBORN; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; BRONCHOPULMONARY DYSPLASIA; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 85008413138     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-2511     Document Type: Article

References (35)

1. McEvoy CT, Jain L, Schmidt B, Abman S, Bancalari E, Aschner JL. Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorac Soc. 2014;11(suppl 3):S146-S153
2. Kugelman A, Durand M. A comprehensive approach to the prevention of bronchopulmonary dysplasia. Pediatr Pulmonol. 2011;46(12):1153-1165
3. Speer C P. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology. 2009;95(4):353-361
4. Baier RJ, Majid A, Parupia H, Loggins J, Kruger TE. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol. 2004;37(2):137-148
5. Doyle LW, Halliday HL, Ehrenkranz RA, Davis PG, Sinclair JC. An update on the impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk of bronchopulmonary dysplasia. J Pediatr. 2014;165(6):1258-1260
6. Shah VSOA, Ohlsson A, Halliday HL, Dunn M. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev. 2012; (5): CD001969
7. Onland WOM, van Kaam A. Late (>7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants [review]. Cochrane Database Syst Rev. 2012; (4): CD002311
8. Bassler D, Plavka R, Shinwell ES, et al; NEUROSIS Trial Group. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. N Engl J Med. 2015;373(16):1497-1506
9. Shah SS, Ohlsson A, Halliday HL, Shah VS. Inhaled versus systemic corticosteriods for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Cochrane Database Sys Rev. 2012; (5): CD002057
10. Shah SS, Ohlsson A, Halliday HL, Shah VS. Inhaled versus systemic corticosteriods for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev. 2012; (5): CD002058
11. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100
12. Shamseer L, Moher D, Clarke M, et al; PRISMA-P Group. Preferred reporting items for systematic review and metaanalysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647
13. Shinwell ES, Portnov I, Meerpohl J, Karen T, Bassler D. Use of inhaled corticosteroids for the prevention and/or treatment of bronchopulmonary dysplasia in preterm infants: a systematic review protocol. Syst Rev. 2015;4:127
14. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). 2011. Available at: http://handbook.cochrane.org. Accessed October 15, 2016
15. Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401-406
16. Pokriefka E, Mehdizadeh B, Rabbani A. Inhaled flunisolide in bronchopulmonary dysplasia [abstract]. Pediatr Res. 1993;33:341A
17. Arnon S, Grigg J, Silverman M. Effectiveness of budesonide aerosol in ventilator-dependent preterm babies: a preliminary report. Pediatr Pulmonol. 1996;21(4):231-235
18. Giep T, Raibble P, Zuerlein T, Schwartz ID. Trial of beclomethasone dipropionate by metered-dose inhaler in ventilator-dependent neonates less than 1500 grams. Am J Perinatol. 1996;13(1):5-9
19. Denjean A, Paris-Llado J, Zupan V, et al. Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: a randomised double-blind study. Eur J Pediatr. 1998;157(11):926-931
20. Pappagallo M, Abbasi S, Bhutani VK. Respiratory and systemic effects of inhaled dexamethasone on ventilator dependant preterm infants at risk for bronchopulmonary dysplasia. Indian J Pediatr. 1998;65(2):273-282
21. Townsend S F, Hale KA, Thilo EH. Early treatment with inhaled steroids does not improve outcome in extremely premature infants with respiratory distress [abstract]. Pediatr Res. 1998;43:300A
22. Fok TF, Lam K, Dolovich M, et al. Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed. 1999;80(3):F203-F208
23. Cole CH, Colton T, Shah BL, et al. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. N Engl J Med. 1999;340(13):1005-1010
24. Merz U, Kusenbach G, Häusler M, Peschgens T, Hörnchen H. Inhaled budesonide in ventilator-dependent preterm infants: a randomized, double-blind pilot study. Biol Neonate. 1999;75(1):46-53
25. Yong WSC, Carney S, Pearse RG, Gibson AT. The effect of inhaled fluticasone propionate (FP) on premature babies at risk for developing chronic lung disease of prematurity [abstract]. Arch Dis Child. 1999;80:G64
26. Jónsson B, Eriksson M, Söder O, Broberger U, Lagercrantz H. Budesonide delivered by dosimetric jet nebulization to preterm very low birthweight infants at high risk for development of chronic lung disease. Acta Paediatr. 2000;89(12):1449-1455
27. Zimmerman JJ, Gabbert D, Shivpuri C, Kayata S, Miller J, Ciesielski W. Meter-dosed, inhaled beclomethasone initiated at birth to prevent bronchopulmonary dysplasia. Pediatr Crit Care Med. 2000;1(2):140-145
28. Jangaard KA, Stinson DA, Allen AC, Vincer MJ. Early prophylactic inhaled beclomethasone in infants less than 1250 g for the prevention of chronic lung disease. Paediatr Child Health. 2002;7(1):13-19
29. Dugas MA, Nguyen D, Frenette L, et al. Fluticasone inhalation in moderate cases of bronchopulmonary dysplasia. Pediatrics. 2005;115(5). Available at: www.pediatrics.org/cgi/content/full/115/5/e566
30. La Force WR, Brudno DS. Controlled trial of beclomethasone dipropionate by nebulization in oxygen- and ventilator-dependent infants. J Pediatr. 1993;122(2):285-288
31. Fischer HS, Bührer C. Avoiding endotracheal ventilation to prevent bronchopulmonary dysplasia: a metaanalysis. Pediatrics. 2013;132(5). Available at: www.pediatrics.org/cgi/content/full/132/5/e1351
32. Dargaville PA, Aiyappan A, De Paoli AG, et al. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure. Arch Dis Child Fetal Neonatal Ed. 2013;98(2):F122-F126
33. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Surfactant administration via thin catheter during spontaneous breathing: randomized controlled trial. Pediatrics. 2013;131(2). Available at: www.pediatrics.org/cgi/content/full/131/2/e502
34. Schmidt B. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial. Biol Neonate. 2005;88(3):208-213
35. Shinwell ES, Karplus M, Bader D, et al. Neonatologists are using much less dexamethasone. Arch Dis Child Fetal Neonatal Ed. 2003;88(5):F432-F433